presented by : pharm.d abdulhadi burzangi pharm.d

27
Presented by : Abdulhadi Burzangi Pharm.D Pharm.D

Upload: brice-davis

Post on 11-Jan-2016

257 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Presented by : Pharm.D Abdulhadi Burzangi Pharm.D

Presented by :

Abdulhadi Burzangi Pharm.DPharm.D

Page 2: Presented by : Pharm.D Abdulhadi Burzangi Pharm.D

Introduction Introduction

• all hospital’s pharmacy still complainhng of medications errors problems which lead to increasing number of patients die until now….

• The research for the methods or ways to reduce these medications errors is a great challenge…

• So…we must know more information about medications that consider as High Alert Medications and how to deal with them?

Page 3: Presented by : Pharm.D Abdulhadi Burzangi Pharm.D

Key points Key points

• Definition.• High alert medications.• The top five high-alert medications.• Reduce the risks of high-alert drugs.• Safeguards for the use of high alert

medications.

Page 4: Presented by : Pharm.D Abdulhadi Burzangi Pharm.D

I. Definition I. Definition

• High Alert Medications :

Drugs that bear a heightened risk of causing significant patient harm when they are used in error. Although mistakes may or may not be more common with these drugs, the consequences of an error are clearly more devastating to patients.

Page 5: Presented by : Pharm.D Abdulhadi Burzangi Pharm.D

Classes/Categories of Medications

Adrenergic agonists I.V (e.g, epinephrine, phenylephrine, norepinephrine ).

Adrenergic antagonists I.V ( e.g, propranolol, metoprolol, labetalol )

Anasthetic agents: inhaled and IV ( e.g, propofol, ketamine )

Antiarrhythmics, I.V ( e.g, lidocaine, amiodarone ).

Anticoagulant : (e.g, heparin, warfarin ).

Chemotherapeutic agents : parentral and oral.

Oral hypogylcemics.

Inotropic medications I.V ( e.g, digoxin , milrinone ).

Moderate sedation agents I.V (e.g, midazolam), Oral (e.g, chloral hydrate)

Narcotics/Opiates I.V, transdermal and oral.

Neuromuscular blocking agents ( e.g, succinylcholine).

II. High Alert MedicationsII. High Alert Medications

Page 6: Presented by : Pharm.D Abdulhadi Burzangi Pharm.D

Specific medications

Colchicine injection .

Insulin : S.C and I.V.

Magnesium sulfate injection.

Methotrexate : oral ( non – oncologic use ) .

Oxyticin I.V.

Nitroprusside sodium for injection.

Potassium chloride for injection .

Promethazine I.V.

Sodium chloride for injection.

Cont..

Page 7: Presented by : Pharm.D Abdulhadi Burzangi Pharm.D

1- Insulin.

2- Opiate and Narcotics.

3- Injectable Potassium chloride or phosphate.

4- Injectable Anticoagulant.

5- Sodium chloride solution above 0.9%.

III. The top five high-alert medicationsIII. The top five high-alert medications

Page 8: Presented by : Pharm.D Abdulhadi Burzangi Pharm.D

1- Insulin 1- Insulin

• Hypoglycemia is the most common complication of any insulin therapy.

• Factors contributing to harm :

- Complexity of dosing. - Frequent monitoring. - Pharmacokinetics differ based on insulin type.

III. The top five high-alert medicationsIII. The top five high-alert medications

Page 9: Presented by : Pharm.D Abdulhadi Burzangi Pharm.D

- Many insulin products available :

( look alike – sound alike names )

- Lack of dose check systems - Insulin and heparin vials kept in close proximity to each other

on a nursing unit, leading to mix-ups. - Use of "U" as an abbreviation for "units" in orders (which can be confused with "O," resulting in a 10-fold overdose) - Incorrect rates being programmed into an infusion pump.

Cont..

Page 10: Presented by : Pharm.D Abdulhadi Burzangi Pharm.D

2- Opiates and Narcotics

Factors contributing to harm : • Calculation errors.

• IV to PO conversion errors.

• Errors converting potency when changing from

one narcotic to another.

• Many dosage forms.

Cont..

Page 11: Presented by : Pharm.D Abdulhadi Burzangi Pharm.D

- Parenteral narcotics stored in nursing areas as floor stock. - Confusion between hydromorphone and morphine. - Patient-controlled analgesia (PCA) errors regarding concentration and rate.

• Adverse effet :

- Respiratory depression - Confusion - Lethargy

Cont..

Page 12: Presented by : Pharm.D Abdulhadi Burzangi Pharm.D

3- Injectable Potassium Chloride or Phosphate

• Common Risk Factors

- Storing concentrated potassium chloride/phosphate outside of the pharmacy. - Requests for unusual concentrations.

Cont..

Page 13: Presented by : Pharm.D Abdulhadi Burzangi Pharm.D

Adverse effect :

1- Muscular or respiratory paralysis.

2- Mental confusion. 3- Hypotension. 4- Cardiac arrhythmia. 5- Heart block.

Cont..

Page 14: Presented by : Pharm.D Abdulhadi Burzangi Pharm.D

4- Injectable anticoagulant ( Heparin )

Common Risk Factors

• Narrow therapeutic range.• Complex dosing.• Frequent monitoring.• Patient compliance.• Many interaction : – Other prescription

medication. – OTC medications. – Herbal products. – Food.

Cont..

Page 15: Presented by : Pharm.D Abdulhadi Burzangi Pharm.D

• Common Risk Factors

- Unclear labeling regarding concentration and total

volume. - Multi-dose containers. - Confusion between heparin and insulin due to similar measurement units.

Cont..

Page 16: Presented by : Pharm.D Abdulhadi Burzangi Pharm.D

5- Sodium chloride solution above 0.9%

• Common Risk Factors

- Storing sodium chloride solutions (above 0.9%) on

nursing units. - Large number of concentrations/formulations available. - No double check system in place.

Cont..

Page 17: Presented by : Pharm.D Abdulhadi Burzangi Pharm.D

IV. Reduce the risks of high-alert drugs

• Three formulas:

1. Standardize error-prevention

processes.2. Make errors apparent.3. Minimize the consequences of errors

that reach the patient.

Page 18: Presented by : Pharm.D Abdulhadi Burzangi Pharm.D

1. Standardize error-prevention processes

• Technological aids:

1- Computerized prescriber order entry (CPOE)

2- Bar coding

• Make patient information readily accessible:

Cont..

Page 19: Presented by : Pharm.D Abdulhadi Burzangi Pharm.D

2. Make errors apparent

a. Perform independent double checks

b. Rely on redundancies.

c. Listen for bells and whistles.

Cont..

Page 20: Presented by : Pharm.D Abdulhadi Burzangi Pharm.D

a. Perform independent double checks

• Have another person verify the medication order and infusion pump setting :

– just before you start an infusion.– every time you change an infusion rate.– every time you replace an empty infusion bag or

cassette.

• Use this method exclusively for high-alert drugs to avoid double-check fatigue and complacency.

Cont..

Page 21: Presented by : Pharm.D Abdulhadi Burzangi Pharm.D

b. Rely on redundancies

• Match high-alert drug orders to the patient’s diagnosis, the drug’s indication, and vital patient information.

• If possible, avoid verbal orders. If they’re necessary, write down the order in the chart and then read back:

– patient name– drug order as written– spelling of the drug name

Cont..

Page 22: Presented by : Pharm.D Abdulhadi Burzangi Pharm.D

3. Minimize consequences of errors

A. Closely monitoring the patient’s

- level of consciousness

- vital signs

- respiratory status

- lab results

B. Ensuring that reversal agents and resuscitation equipment are readily available

Cont..

Page 23: Presented by : Pharm.D Abdulhadi Burzangi Pharm.D

V. Safeguards for the use of high alert medications

- Removal high concentrate electrolytes (e.g. potassium chloride, potassium phosphate and sodium chloride) from all nursing units.

- Stop using dangerous abbreviations such as “u”.

- Use of a leading zero before a decimal place.

- Review the hospital formulary for sound-alike and look-alike medications.

Page 24: Presented by : Pharm.D Abdulhadi Burzangi Pharm.D

- Use of “tall man” letters for sound-alike and look-alike names (e.g. DOBUTamine and DOPamine).

- Careful review of how products are arranged on shelves to avoid similar packaged or sound-alike medications being side by side.

- Use flow-control pumps for continuous intravenous (I.V.) infusions.

- Educate patients and family and encourage their participation in care.

Cont..

Page 25: Presented by : Pharm.D Abdulhadi Burzangi Pharm.D

Conclusion

- Use of visible coloured auxiliary warning labels.

• I wish to apply this procedure in this hospital.

Page 26: Presented by : Pharm.D Abdulhadi Burzangi Pharm.D

References

• 5 Million Lives Campaign Getting Started Kit: Prevent Harm from High-Alert Medications How-to Guide. Institute for Healthcare Improvement, 2007.

• http://www.ismp.org/newsletters/acutecare/articles/20070517.asp

Page 27: Presented by : Pharm.D Abdulhadi Burzangi Pharm.D